Skip to main content
. 2022 Nov 2;12:18500. doi: 10.1038/s41598-022-22576-4

Figure 6.

Figure 6

Anti-SARS-CoV-2 activity of CA in cell assays. In vitro replication assays performed in Vero CCL81 (A) and Calu-3 (B) cells. Cells were infected with SARS-CoV-2 for 1 h and later incubated with fresh media containing CA at 25 µM or 100 µM. The viral load was quantified by the plaque assay (PFU/ml) in the cell supernatants collected 48 h post-infection. (C) Virucidal assays performed in Vero CCL-81 cells, where SARS-CoV-2 particles were incubated with CA at 25 µM or 100 µM for 1 h and then used to infect the cells for 1 h. The viral load was quantified using the plaque assay to assess the infectious viral progeny. DMSO at 0.2% final concentration was used as control. p ≤ 0.05 (*), p ≤ 0.01 (**), p ≤ 0.001 (***). Results are expressed as individual values (n = 8 for replication assay and n = 4 for virucidal assay) with mean +/− standard deviation.